Zepbound has at least five different prices depending on which door you walk through, and most cost articles quote only the scariest one. Here is the full price map as of August 2026, cheapest legitimate door first, with the moving parts flagged: this market reprices constantly, so verify the numbers the week you buy.
The price map
| Door | Typical cost | The catch |
|---|---|---|
| Insurance with coverage | Plan copay, often $25 to $100/mo with the savings card | Coverage for obesity indications is the exception, not the rule; prior authorization fights are standard |
| LillyDirect self-pay vials | From about $349/mo (2.5 mg) and $499/mo (higher doses) | Vial-and-syringe format rather than pens; prices and included doses have shifted several times |
| Savings card (commercially insured) | Reduces copays substantially when coverage exists | Excludes government insurance; terms change yearly |
| Retail pharmacy list | Around $1,060/mo before any help | The sticker nobody should actually pay |
| Compounded tirzepatide | Historically $150 to $400/mo | The lane narrowed sharply post-shortage; Lilly litigates; product consistency varies |
The LillyDirect vials: the door that changed the market
Lilly's self-pay vial program is the structural answer to the compounding era: brand-authentic tirzepatide at prices designed to undercut the gray market's reason to exist. The trade-offs are format (drawing from a vial with a syringe instead of clicking a pen, which makes our calculator relevant to brand users for the first time) and dose availability, which Lilly has adjusted repeatedly. For self-pay buyers it is almost always the rational first check.
Costco, GoodRx, and the pharmacy-shopping question
Discount cards and warehouse pharmacies matter far less for Zepbound than people hope: brand-drug list prices leave little room, and programs bolted onto membership retailers have come and gone quickly in this category. Treat any 'Zepbound at [retailer] for $X' claim as dated until verified that week; the durable savings doors are insurance coverage, the savings card, and LillyDirect, in that order.
Making the insurance door open
- Coverage follows diagnosis language: obesity with comorbidities, or the OSA indication, documented in the chart, beats 'weight loss' on every prior authorization form.
- Denials are appealable and appeals work often enough to be worth the letter; prescriber offices do this daily.
- Employer plans differ wildly on GLP-1 coverage; open-enrollment season is genuinely a Zepbound pricing event.
- Veterans: the VA path has its own rules and single-digit copays; see our VA coverage guide.
Frequently asked questions
How much is Zepbound without insurance?
List price sits near $1,060 a month, but self-pay buyers should look at LillyDirect vials first: from about $349 a month at the starting dose and $499 at higher tiers as of mid-2026, brand-authentic and designed exactly for the no-coverage case.
How do I get Zepbound for $25 a month?
That is the savings-card scenario: commercial insurance that covers Zepbound plus Lilly's card bringing the copay down. It requires actual coverage (government plans excluded) and the card's yearly terms; without coverage, the card does not create the low price.
Is compounded tirzepatide still cheaper?
Often, at $150 to $400 monthly where still offered, but the post-shortage legal lane narrowed hard, Lilly litigates against sellers, and LillyDirect's vial pricing removed most of the price gap that justified the risk. The calculus that favored compounding in 2024 mostly no longer does.